Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction.
Dan HabermanRodrigo Estévez-LoureiroTomás Benito GonzálezPaolo DentiDabit ArzamendiMarianna AdamoXavier FreixaLuis Nombela-FrancoPedro VillablancaLian KrivosheiNeil FamKonstantinos SpargiasAndrew CzarneckiIsaac PascualFabien PrazDoron SudarskyArthur KernerVlasis NiniosMarco GennariRonen BeeriLeor PerlYishay WasserstrumHaim DanenbergLion PolesJacob GeorgeBerenice Caneiro-QueijaSalvatore SciannaIgal MoarafDavide SchiaviClaudia ScardinoNoé CorpatauxJulio Echarte-MoralesMichael ChrissoherisEstefania Fernández-PeregrinaMattia Di PasqualeAnder RegueiroCarlos Eduardo Vergara-UzcateguiAndres Iñiguez-RomoFelipe Fernández-VazquezDanny DvirFrancesco MaisanoMaurizio TaramassoMony ShuvyPublished in: European heart journal (2021)
Early intervention may mitigate the poor prognosis associated with conservative therapy in patients with post-MI MR. Percutaneous mitral valve repair can serve as an alternative for surgery in reducing MR for high-risk patients.
Keyphrases
- poor prognosis
- minimally invasive
- acute myocardial infarction
- end stage renal disease
- long non coding rna
- newly diagnosed
- randomized controlled trial
- ejection fraction
- chronic kidney disease
- ultrasound guided
- peritoneal dialysis
- prognostic factors
- contrast enhanced
- percutaneous coronary intervention
- coronary artery bypass
- magnetic resonance imaging
- coronary artery disease
- mesenchymal stem cells
- bone marrow
- patient reported